Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20739195 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type II
Interventions: Drug: T0903131 Besylate;   Drug: Placebo

Indicates status has not been verified in more than two years